The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Chr. Hansen Receives Joint Innovation Fund Grant to Develop Next Generation Microbial Solutions for Agriculture
Phytobiome & Environment

Chr. Hansen Receives Joint Innovation Fund Grant to Develop Next Generation Microbial Solutions for Agriculture

NOV 6, 2018
Vedanta Biosciences Announces Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate
Oncology

Vedanta Biosciences Announces Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate

NOV 6, 2018
Elanco Announces Collaboration Agreement with Novozymes for Nutritional Health Innovation
Animal Health

Elanco Announces Collaboration Agreement with Novozymes for Nutritional Health Innovation

NOV 2, 2018
Understanding the Microbiome of Watermelon Snow in the Context of Climate Change
Phytobiome & Environment

Understanding the Microbiome of Watermelon Snow in the Context of Climate Change

NOV 1, 2018
OxThera Presents Encouraging 52-Week Efficacy and Safety Data for Oxabact® in Primary Hyperoxaluria Type 1 (PH1) Patients with ESRD
Pharma & Human Health

OxThera Presents Encouraging 52-Week Efficacy and Safety Data for Oxabact® in Primary Hyperoxaluria Type 1 (PH1) Patients with ESRD

OCT 31, 2018
Researchers Identify Three Distinct Stages in Infant Microbiome Development
Editor's Choice

Researchers Identify Three Distinct Stages in Infant Microbiome Development

OCT 26, 2018
Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital™ Fund
Finance

Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital™ Fund

OCT 25, 2018
ConsortiaTX Awarded Exclusive License for Food Allergy Microbial Therapy
Pharma & Human Health

ConsortiaTX Awarded Exclusive License for Food Allergy Microbial Therapy

OCT 24, 2018
Gut Bacteria May Play Role in Heart Attack Recovery
Animal Health

Gut Bacteria May Play Role in Heart Attack Recovery

OCT 24, 2018
Enterome Signs Global Licensing, Co-development and Co-promotion Agreement with Takeda for the Treatment of Crohn’s Disease
Finance

Enterome Signs Global Licensing, Co-development and Co-promotion Agreement with Takeda for the Treatment of Crohn’s Disease

OCT 23, 2018
Rebiotix and Microbiome Insights Collaborate on a Microbiome IBD Tool for Clinical Development
Gastrointestinal

Rebiotix and Microbiome Insights Collaborate on a Microbiome IBD Tool for Clinical Development

OCT 22, 2018